Cannabis Business Insights: Specials Magazine

Symple Seeds simplifies how premium cannabis seeds from leading global breeders reach the U.S. market through its end-to-end, seed-to-sale model. Specializing in seeds, clones and tissue culture solutions, it manages every stage of the supply chain, from growing and packaging to shipping, storage and quality testing for breeders and seed brands primarily from Europe. The fully integrated approach has earned Symple Seeds a reputation as the Amazon of the cannabis seed world. Armed with over a decade of experience, warehouses across the U.S. and strong relationships with leading breeders worldwide, it has shipped nearly a million orders and helped numerous cannabis businesses scale efficiently and compliantly. “We have created a pathway for breeders to bring their legitimate seeds to the U.S. customers and operate like a normal business,” says Jessica Hanson, owner. Building on that success, Symple Seeds now serves as the logistics backbone for the broader alternative wellness industry. It extends its expertise to products including functional mushrooms, kratom, THCA, supplements and peptides. The Breeder’s Advantage Symple Seeds offers a flexible, full-service model that adapts to every stage of a breeder’s journey. Those who produce seeds and seek access to the U.S. market rely on the company’s 10,000-square-foot, climate-controlled warehouse for storage, inventory management and fulfillment. Each batch undergoes in-house vigor and germination testing to ensure that the plants grow strong and healthy. Once orders are placed, Symple Seeds provides compliant U.S. packaging support and ships them. Its system integrates with client software, enabling real-time visibility. The company also features seeds on partner websites and marketplaces, boosting sales opportunities.

Medical cannabis has gained recognition as a clinically proven form of medicine, offering relief to patients managing chronic and neurological illnesses. Despite its promise, access remains limited by restrictive laws in many regions. CannaSense was founded to address this disparity. “Patients once had to travel across the country to have access to medical cannabis,” says Neil Schloss, founder and CEO. “With CannaSense, they can now complete the entire process from home, safely and legally.” For Schloss, the lack of access to medical cannabis had a profound impact when his mother passed away after battling breast cancer. Soon after the personal loss, he learned about medical cannabis and discovered Rick Simpson Oil (RSO), which was gaining attention for its medical benefits. Access to such products on the East Coast was nonexistent, prompting him to find compliant, patient-safe alternatives. He founded CannaSense with a vision to create a system that combines technology with compliance to ensure safe and reliable care. CannaSense unites healthcare professionals, caregivers and patients within a protected, web-based system. This enables consultations, verification and product fulfillment, all in adherence with the Compassionate Use Act of 1996, the first U.S. law to establish medical cannabis standards and patient protection. Today, it operates as a total wellness provider that integrates education, medical evaluation and safe product distribution into one seamless process. Through its secure online system, patients can consult licensed physicians, an option later reinforced by the Affordable Healthcare Act, and receive valid recommendations for treatment. Following physician approval, patients are given access to a secure portal where they can select the finest medicinal cannabis products in various forms, including vape, tincture, topical and edibles. All orders are shipped through reputable carriers, with comprehensive tracking provided for transparency and assurance.